Epstein–Barr Virus Infection and Multiple Sclerosis: A Review

@article{Ascherio2010EpsteinBarrVI,
  title={Epstein–Barr Virus Infection and Multiple Sclerosis: A Review},
  author={Alberto Ascherio and Kassandra L Munger},
  journal={Journal of Neuroimmune Pharmacology},
  year={2010},
  volume={5},
  pages={271-277}
}
Epstein–Barr virus (EBV) infection results in a life-long persistence of the virus in the host’s B-lymphocytes and has been associated with numerous cancers including Burkitt’s lymphoma, Hodgkin lymphoma, and nasopharyngeal carcinoma. There is considerable evidence that EBV infection is a strong risk factor for the development of multiple sclerosis. Early age at primary EBV infection is typically asymptomatic, but primary infection during adolescence or adulthood often manifests as infectious… Expand
Epstein–Barr virus and multiple sclerosis
TLDR
There is strong evidence however that people with MS are more likely to report a past history of infectious mononucleosis (thought to represent initial EBV infection at an older age), and higher titres of EBV specific antibodies are associated with an increased risk of developing MS. Expand
Epstein-barr virus in the central nervous system and cervical lymph node of a patient with primary progressive multiple sclerosis.
TLDR
Using in situ hybridization and immunohistochemistry, EBV is analyzed for the first time in both postmortem CNS and lymph nodes from a patient with primary progressive MS. Expand
Risk of Multiple Sclerosis in Epstein–Barr Virus Infection
TLDR
Several ecological studies, co-occurring pathologies, and experimental laboratory-based research provide evidence to support the relationship between EBV and MS. Expand
Epstein Barr Virus: Development of Vaccines and Immune Cell Therapy for EBV-Associated Diseases
  • Xinle Cui, C. Snapper
  • Medicine
  • Frontiers in Immunology
  • 2021
TLDR
The inclusion of gH/gL and gB in a vaccine formulation with gp350 represents a promising approach of EBV prophylactic vaccine development, and has the potential to increase the efficacy of a therapeutic EBV vaccine. Expand
Epstein-Barr virus and multiple sclerosis: Updating Pender's hypothesis.
TLDR
Mechanisms through which EBV may increase MS risk are reviewed here and EBV-free memory B cells in the CNS may have descended from a memory B cell which matured while containing EBV episomes, enabling its B cell receptor to recognize "forbidden" MS-causing antigens in theNS, even if EBV is absent from this site. Expand
Epstein-Barr Virus Infection in the Development of Neurological Disorders.
TLDR
Property of EBV infection is reviewed that may shed light on its potential pathogenic role in neurological disorders and the effect of chronicEBV infection on the immune system is thought to contribute to pathogenesis, especially auto-immune disease. Expand
Epstein-Barr virus in the multiple sclerosis brain - An evasive culprit.
  • M. Pender
  • Medicine
  • Multiple sclerosis and related disorders
  • 2012
TLDR
To appreciate how EBV might contribute to the development of MS it is necessary to understand some key features of EBV infection. Expand
Investigating the role of Epstein-Barr virus in the pathogenesis of Multiple Sclerosis
TLDR
This research investigates the significance of EBV immune responses, including those targeting the novel epitope EBNA-1(398-413), previously associated with MS risk in disease-discordant identical twins, and identifies novel and statistically powerful relationships between environmental and genetic MS risk factors. Expand
The Role of Latently Infected B Cells in CNS Autoimmunity
TLDR
Animal models, such as experimental autoimmune encephalomyelitis and murine gammaherpesvirus-68 (γHV-68), can be used as powerful tools in the study of the relationship between EBV, MS, and B cells. Expand
The role of Epstein-Barr virus in the etiology of multiple sclerosis: a current review
  • K. Ruprecht
  • Medicine
  • Expert review of clinical immunology
  • 2020
TLDR
The mechanism of EBV in MS is a pressing question, whose clarification may substantially advance the pathophysiological understanding, rational therapies, and prevention of MS. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 85 REFERENCES
Epstein-Barr virus infection is not a characteristic feature of multiple sclerosis brain.
TLDR
The finding that CNS Epstein-Barr virus infection was rare in multiple sclerosis brain indicates that EBV infection is unlikely to contribute directly tomultiple sclerosis brain pathology in the vast majority of cases. Expand
Dysregulated Epstein-Barr virus infection in the multiple sclerosis brain
TLDR
Findings from this study are interpreted as evidence that EBV persistence and reactivation in the CNS play an important role in MS immunopathology. Expand
Primary infection with the Epstein‐Barr virus and risk of multiple sclerosis
TLDR
It is concluded that MS risk is extremely low among individuals not infected with EBV, but it increases sharply in the same individuals following EBV infection. Expand
Epstein-Barr virus in pediatric multiple sclerosis.
TLDR
Serological evidence for remote EBV infection was present in 83% of pediatric MS patients compared with 42% of emergency department and healthy controls, and results suggest an association betweenEBV infection and pediatric MS. Expand
Strong EBV-specific CD8+ T-cell response in patients with early multiple sclerosis.
TLDR
The data show high levels of CD8+ T-cell activation against EBV--but not CMV--early in the course of MS, which support the hypothesis that EBV might be associated with the onset of this disease. Expand
Absence of Epstein-Barr virus in the brain and CSF of patients with multiple sclerosis
TLDR
Application of real-time PCR to multiple sclerosis brain and single B-lymphocytes in CSF did not reveal any evidence of active Epstein-Barr virus infection. Expand
Epstein-Barr virus and disease activity in multiple sclerosis
TLDR
There was no evidence for increased clinical disease activity in the subgroup of MS patients with serological signs of EBV reactivation, however, the observation that chronic EBv reactivation may be associated with increased inflammatory activity as assessed by gadolinium enhanced MRI lesions should be reproduced in a larger and independent dataset. Expand
Association between clinical disease activity and Epstein–Barr virus reactivation in MS
TLDR
The results demonstrate an association between EBV reactivation and disease activity in MS patients over time, and suggest that EBV might play an indirect role in MS as an activator of the underlying disease process. Expand
Epstein Barr virus is not a characteristic feature in the central nervous system in established multiple sclerosis.
TLDR
It is shown that there is little evidence for the presence of EBV in the central nervous system of people with multiple sclerosis, and the studies reveal the vagaries of pathological detection methods for infectious agents such as EBV. Expand
An altered immune response to Epstein-Barr virus in multiple sclerosis
TLDR
Individuals who will develop MS exhibit an altered immune response against the EBV virus characterized by a high IgG activity to EBNA-1 in the absence of high activity to VCA, this being most pronounced in the 5-year period preceding MS onset. Expand
...
1
2
3
4
5
...